Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Split-dose methotrexate had greater efficacy and reduced the need for additional disease-modifying ...

Risk of isolated central nervous system (CNS) involvement was found to be significantly lower in patients with diffuse large B-cell lymphoma who received high-dose methotrexate vs RCHOP chemotherapy, ...

Greater risks of toxic effects were found at higher methotrexate doses and lower eGFR. Older patients with chronic kidney disease (CKD) starting low-dose methotrexate rather than hydroxychloroquine ...

A total of 180 participants worldwide completed the survey, which was conducted in 3 rounds. Members of the SPIN working group identified 7 items related to methotrexate dosage: test dose, start dose, ...

Although high-dose methotrexate is widely accepted as the most effective chemotherapeutic agent for primary CNS lymphoma, no optimal dose or dosing strategy has been established. Researchers from the ...

SAN DIEGO — A split dose of methotrexate (MTX) given orally once per week showed significantly higher efficacy in patients with rheumatoid arthritis (RA) at 16 weeks compared with a single MTX dose ...

Please provide your email address to receive an email when new articles are posted on . Methotrexate and low-dose prednisone combination allowed complete hair regrowth in up to 31% of patients. Only ...

The findings add complexity to questions about the long-term impact of acute lymphoblastic leukemia (ALL) therapy. A new report shows high cumulative doses of intravenous methotrexate can have ...

Exploring Pediatric Oncology Care Practices Influencing the Relationships Among Children, Caregivers, and Health Care Providers: A Multi-Institutional Study From Pakistan HD-MTX dosed at 3,000 mg/m 2 ...

A prospective trial of prophylaxis and treatment (P+T) of acute tumor lysis syndrome (ATLS) with rasburicase (R) and nonalkaline hydration in children and adolescents (C+A) with intermediate- (Group B ...

CHICAGO, IL—Low-dose methotrexate, a nonspecific anti-inflammatory agent used for the treatment of rheumatoid arthritis and other autoimmune disorders, failed to prevent cardiovascular events among ...